Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy.
about
Radiotherapy for advanced-stage aggressive non-Hodgkin lymphomaRadiotherapy and "new" drugs-new side effects?Treatment of diffuse large B cell lymphomaPrimary Breast Lymphoma in a Woman: A Case Report and Review of the LiteratureApproach to therapy of diffuse large B-cell lymphoma in the elderly: the International Society of Geriatric Oncology (SIOG) expert position commentaryPretransplant FDG-PET in aggressive non-Hodgkin lymphoma: systematic review and meta-analysis.Is there a role for consolidative radiotherapy in the treatment of aggressive and localized non-Hodgkin lymphoma? A systematic review with meta-analysis.Radioimmunotherapy with (131)I-rituximab as consolidation therapy for patients with diffuse large B-cell lymphoma.Isolated secondary CNS relapse in a case of stage I diffuse large B-cell lymphoma.Treatment outcome of diffuse large B-cell lymphoma involving the head and neck: Two-institutional study for the significance of radiotherapy after R-CHOP chemotherapy.Primary diffuse large B-cell lymphoma of the bone: bendamustine and rituximab are able to overcome resistant diseaseMy treatment approach to patients with diffuse large B-cell lymphoma.Endoscopic features of gastro-intestinal lymphomas: from diagnosis to follow-up.Predictors of local recurrence after rituximab-based chemotherapy alone in stage III and IV diffuse large B-cell lymphoma: guiding decisions for consolidative radiationPredictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphomaConsolidation Radiotherapy in Stage IE- IIE, Non-Bulky Primary Gastric Diffuse Large B-Cell Lymphoma with Post-Chemotherapy Complete Remission.Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial.Addition of rituximab is not associated with survival benefit compared with CHOP alone for patients with stage I diffuse large B-cell lymphoma.CHOP Chemotherapy for Aggressive Non-Hodgkin Lymphoma with and without HIV in the Antiretroviral Therapy Era in Malawi.Analysis of prognostic factors in patients with newly diagnosed diffuse large B-cell lymphoma and skeletal involvement.Radiotherapy dose-response analysis for diffuse large B-cell lymphoma with a complete response to chemotherapyA phase II trial of RCHOP followed by radioimmunotherapy for early stage (stages I/II) diffuse large B-cell non-Hodgkin lymphoma: ECOG3402Efficacy and safety of rituximab combined with chemotherapy in the treatment of diffuse large B-cell lymphoma: a meta-analysis.Excellent outcomes and lack of prognostic impact of cell of origin for localized diffuse large B-cell lymphoma in the rituximab era.Surgical decompression improves recovery from neurological deficit and may provide a survival benefit in patients with diffuse large B-cell lymphoma-associated spinal cord compression: a case-series study.The role of radiotherapy for patients over age 60 with diffuse large B-cell lymphoma in the rituximab era.Phase II study of pazopanib monotherapy in metastatic gastroenteropancreatic neuroendocrine tumoursClinical implications of positron emission tomography-negative residual computed tomography masses after chemotherapy for diffuse large B-cell lymphoma.Analysis of treatment outcomes for primary tonsillar lymphomaThe Roles of Radiotherapy and Immunotherapy for the Treatment of LymphomaClinical features, management, and prognosis of an international series of 161 patients with limited-stage diffuse large B-cell lymphoma of the bone (the IELSG-14 study).The important role of radiation therapy in early-stage diffuse large B-cell lymphoma: time to review the evidence once again.Sunitinib for advanced pancreatic neuroendocrine tumors.Limited-stage diffuse large B-cell lymphoma treated with abbreviated systemic therapy and consolidation radiotherapy: involved-field versus involved-node radiotherapy.Translation of molecular pathways into clinical trials of neuroendocrine tumors.Renewed interest in the role of consolidative radiotherapy in advanced stage diffuse large B-cell lymphoma.The role of radiation therapy in the treatment of stage I-II diffuse large B-cell lymphoma.Modern radiotherapeutic strategies in the management of lymphoma.Prognostic value of complete remission status at end-of-treatment FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma: systematic review and meta-analysis.The importance of radiotherapy on diffuse large B cell lymphoma treatment: a current review.
P2860
Q24187708-4A2AADD5-05B4-42EA-B766-DA582BDED2E8Q26861498-F23B40C4-0A81-45B1-BE3B-9B5001358A8DQ27006062-5BA28090-0E0C-4E6F-8999-ED08AACECE05Q28078192-320AE620-CA6C-4673-8AB2-BF278F6C236FQ28088365-9064BB92-1F7F-4DC3-8451-FC585E7D7DDAQ30240084-3B23CEDC-9D40-4E9D-95DD-946C7CACC886Q31072157-2449A137-78AD-4C2B-8D14-9E9218813433Q33434959-04ECAF46-B8F4-4A8A-B943-6A4DD9E66520Q33625864-F3E2C067-2371-4BB9-BB99-1F3ABFEB9F15Q33833821-07F9F91F-31FD-440D-922D-9ABEEEA7C526Q33911781-0EE4C38E-BF9F-4511-8790-7C8F2CB64973Q34251964-A2885642-5765-402F-B082-12445E6600C3Q34255507-957C9063-21C0-4974-892E-97F0543C72B7Q35377526-FAB082A9-0622-4D5E-A03D-48C8C5D531C4Q35564776-B72920EA-7016-4AB4-A2E0-91C8C32B38C0Q35700505-5DEE3AC1-D10A-445C-AC4F-9795A359E983Q35800846-43C0776A-A3DB-4768-AD51-B66F99B28418Q35834336-F5A48C37-56B5-4CE6-A34B-7BBF624EFA17Q35942794-6D0C294E-B870-4028-A8B0-6BF0EF1BF2B4Q36279071-FC080C8E-9DA5-45C1-95B6-5B8A4C9B768CQ36299343-9A15A459-C2B2-4440-AFC9-D65CEB16A129Q36404383-86130868-1689-4883-8D97-02992D5660D5Q36411549-EA77B4A7-1F3E-4E30-A678-01B9C48CE926Q36469899-7B5CC10A-0207-4045-8D4C-7E5520F34677Q36964299-D6AA1A4A-59B9-4F1D-B792-1BB96917AF35Q37104282-694387FE-9BEC-4C57-A5DD-99104BCED257Q37182210-BA674C2E-E596-4B70-8521-6855A4444B7EQ37307649-C934E525-3D4C-4459-84FE-019D6AAE0457Q37551767-E6C65955-4022-43E5-9DBA-F8BDCB4EA1EBQ37640319-CE90F994-E459-49CF-9225-096CCC83C4A7Q37644528-5CB6C66F-9ADF-4159-A025-E2D5119027C2Q37934960-ACC38AA5-7A66-424D-9DDE-9C58D3F4C935Q37960905-0DAA4226-B03A-4F49-84DA-0E42485175E7Q37976607-B9A35380-865E-46EF-B89A-F47971C005CFQ38003074-25E84384-DDF7-4F87-AF0F-4E54200C50A6Q38085077-DFB293D0-5703-492D-8890-75A6303FE722Q38125428-F5E44D21-1CAE-486F-9C34-08ACFAB312A0Q38373945-96921DB0-188B-4A18-A1D8-BD7DD6A9DA82Q38400848-502CAC2B-2EC4-4E95-B1D6-C2A7C57D019AQ38565503-1BE7CC1D-EA0B-4034-9906-3F85FE1E7012
P2860
Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Benefit of consolidative radia ...... ated with R-CHOP chemotherapy.
@en
Benefit of consolidative radia ...... ated with R-CHOP chemotherapy.
@nl
type
label
Benefit of consolidative radia ...... ated with R-CHOP chemotherapy.
@en
Benefit of consolidative radia ...... ated with R-CHOP chemotherapy.
@nl
prefLabel
Benefit of consolidative radia ...... ated with R-CHOP chemotherapy.
@en
Benefit of consolidative radia ...... ated with R-CHOP chemotherapy.
@nl
P2093
P356
P1476
Benefit of consolidative radia ...... ated with R-CHOP chemotherapy.
@en
P2093
Ali Mazloom
Bouthaina Shbib Dabaja
Christine Wogan
Ferial Shihadeh
L Jeffrey Medeiros
Luis Fayad
Maria Alma Rodriguez
Nathan Fowler
Patrecia Horace
P304
P356
10.1200/JCO.2009.27.3441
P407
P577
2010-08-16T00:00:00Z